Nutri Pharma ASAKronprinsesse Marthas
Plass 1 P.O Box 1477, Vika N-0116 Oslo Norway Telephone +47 23 01 09 60 Telefax +47 23 01 09 70 Send e-mail |
Corporate Governance in Nutri PharmaGood corporate governance is characterised by responsible interaction between the owners, the Board of Directors and its management, viewed in both a short and longer term, value creation perspective. Shareholders, employees, customers, suppliers, lenders, public authorities and society in general should be able to trust that a business is being run properly and that governing bodies are sufficiently independent in order to perform their functions. Corporate governance deals with issues and principles related to the distribution of roles between the governing bodies of a company and the responsibility and authority assigned to each of those bodies. Proper attention must be given to the various roles and function of a Board of Directors to both foster proper controls, but at the same time encourage the business to assume risks and manage risks by encouraging innovation and entrepreneurship; all with the aim to enhance shareholder values. Proper attention must also be given to the characteristics of the Company participating in the business community where speed of decision making and in execution over time has been a core competitive advantage. This document outlines key principles and guidelines for the governance of Nutri Pharma. These principles and guidelines are approved by the Board of Directors and are to be reviewed annually or more often if deemed necessary.
Ethics and social responsibility
Business activities The articles of association of Nutri Pharma ASA states that; the company business is; industry, trade, consultancy and administration of owned and rented property and rights, including participation in other companies through shares. The current articles of association of the company are disclosed in their entirety on our web. The Board of Directors and management have determined the current strategic direction for the Company to be to become a major supplier of health care and cosmetics products based on long-term product rights and ownership, through direct sales in various markets internationally. |